After a boom in the stock prices of Canadian licensed producers (LPs) in 2016 that left the average stock up more than 355%, the sector is performing very well...
PharmaCan Capital Announces $15 Million Bought Deal TORONTO, ONTARIO–(Marketwired – Feb. 14, 2017) – PharmaCan Capital Corp., doing business as Cronos Group (TSXV: MJN) (OTC: PRMCF) (“Cronos” or the...
Statement from Health Canada on the Testing of Cannabis for Medical Purposes for Unauthorized Pest Control Products OTTAWA, Feb. 7, 2017 /CNW/ – Recently, two licensed producers of cannabis...
Last week, James West of the Midas Letter published interviews of four CEOs of publicly-traded Canadian licensed producers, including Vic Neufeld of Aphria (TSXV: APH) (OTC: APHQF), Brent Zettl of...
Perhaps the biggest story of 2016 in the cannabis capital markets was the surge in prices and the amount of capital raised for the cannabis industry in Canada during...
PharmaCan Announces Corporate Rebranding to Become Cronos Group TORONTO, ON–(Marketwired – October 06, 2016) – PharmaCan Capital (TSXV: MJN) (“the Company”) today announced a corporate rebranding to Cronos Group....
Following up on its July announcement that it would be buying Peace Naturals, PharmaCan Capital (TSXV: MJN) (OTC: PRMCF) announced today that the deal has closed, creating the first licensed producer (LP)...
When Justin Trudeau and the Liberal Party won a majority of seats in the Canadian Parliament elections in October last year, it set off a quick pop in the...
PharmaCan Capital (TSXV: MJN) (OTC: PRMCF) announced that it will acquire Peace Naturals Project in a deal that is expected to close by the end of Q3. The company will be...
Despite a rapidly growing underlying industry, investors in the publicly-traded cannabis stocks have been dodging landmines for several years now, with few companies producing solid returns so far and...
Co-founder, President and CEO Paul Rosen has resigned from PharmaCan Capital (TSXV:MJN). Rosen, a pioneer in the Canadian cannabis industry, created a merchant bank to invest in the industry...
The Auditor General of Canada presented the results of five audits to Parliament today, one of which covered Veterans Affairs Canada: Our Spring reports also provide the results of our most...
After waiting more than six months, cannabis producers Tilray, which is owned by Privateer Holdings, Tweed, a subsidiary of Canopy Growth (TSXV: CGC), and Whistler Medical, partially owned by...
Alan Brochstein published an article on the publicly-traded Canadian cannabis stocks, including Aphria, Aurora Cannabis, Canopy Growth, Emerald Health, Mettrum, OrganiGram, PharmaCan Capital and Supreme Pharma. The article, which is...
One of the most exciting aspects of the global cannabis legalization has been the progress since the 2014 implementation of the federally legal medical cannabis program in Canada, MMPR,...
We publish a lot of content on the Canadian cannabis industry at New Cannabis Ventures. 15% of our visitors reside in Canada, perhaps consequently, and I spend a great deal of...
Alan Brochstein, CFA, discussed the “State of the Legal Canadian Cannabis Industry” at the eMoneyShow Virtual Conference on 10/30/15: One of the biggest barriers to investing in cannabis companies is that...
CBC News highlights the plight of Vert Médica, one of many applicants under Health Canada’s MMPR program that has been waiting for inspection. Dany Lefebvre has a sleek, modern production...
One of the highlights of the National Cannabis Summit in Denver was the 90-minute panel entitled “Investing in the Canadian Cannabis Sector”. The participants included the CEO of merchant...
